Published in J Biomed Biotechnol on December 16, 2009
Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci (2013) 1.31
Perivascular cells for regenerative medicine. J Cell Mol Med (2012) 1.29
Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World J Stem Cells (2014) 1.16
Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev (2013) 1.14
Human umbilical cord perivascular cells (HUCPVC): A mesenchymal cell source for dermal wound healing. Organogenesis (2011) 1.02
Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol (2010) 0.92
Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng Part B Rev (2012) 0.91
Release of bioactive adeno-associated virus from fibrin scaffolds: effects of fibrin glue concentrations. Tissue Eng Part A (2011) 0.91
Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during Prolonged In Vitro Expansion: Considerations for Cytotherapy. Stem Cells Int (2013) 0.90
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood. Biomed Res Int (2013) 0.89
The role of cell surface markers and enamel matrix derivatives on human periodontal ligament mesenchymal progenitor responses in vitro. Biomaterials (2011) 0.89
Isolation and characterization of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line. PLoS One (2011) 0.89
Cryopreservation of human vascular umbilical cord cells under good manufacturing practice conditions for future cell banks. J Transl Med (2012) 0.89
Umbilical cord as a mesenchymal stem cell source for treating joint pathologies. World J Orthop (2011) 0.86
Effects of serial passage on the characteristics and chondrogenic differentiation of canine umbilical cord matrix derived mesenchymal stem cells. Asian-Australas J Anim Sci (2013) 0.85
Human muscle-derived cell populations isolated by differential adhesion rates: phenotype and contribution to skeletal muscle regeneration in Mdx/SCID mice. Tissue Eng Part A (2011) 0.84
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique? J Transl Med (2015) 0.77
Label-Free Imaging of Umbilical Cord Tissue Morphology and Explant-Derived Cells. Stem Cells Int (2016) 0.77
Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications. Open Biomed Eng J (2013) 0.76
Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure. Stem Cells Transl Med (2016) 0.76
The assessment of CD146-based cell sorting and telomere length analysis for establishing the identity of mesenchymal stem cells in human umbilical cord. F1000Res (2014) 0.75
Activation of the Extracellular Signal-Regulated Kinase Signaling Is Critical for Human Umbilical Cord Mesenchymal Stem Cell Osteogenic Differentiation. Biomed Res Int (2016) 0.75
Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies. Front Neurosci (2017) 0.75
Evaluation of Tissue Homogenization to Support the Generation of GMP-Compliant Mesenchymal Stromal Cells from the Umbilical Cord. Stem Cells Int (2016) 0.75
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell (2007) 10.13
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell (2008) 7.47
Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell (2008) 6.26
Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res (2003) 5.23
Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells (2004) 4.31
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A (1989) 4.13
Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells (2007) 3.79
All MSCs are pericytes? Cell Stem Cell (2008) 3.12
Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells (2005) 3.03
Matrix cells from Wharton's jelly form neurons and glia. Stem Cells (2003) 2.95
Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells (2005) 2.74
Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol (2008) 2.68
Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod (2007) 2.37
Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells (2007) 2.20
Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells (2006) 2.08
Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther (2007) 2.00
Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell (2005) 1.91
Stem cell collection and gene transfer in Fanconi anemia. Mol Ther (2007) 1.81
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol (2008) 1.68
Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell (2005) 1.42
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med (2006) 1.34
Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins (2000) 1.30
History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy (2005) 1.19
Tolerance strategies for stem-cell-based therapies. Nature (2008) 1.18
Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res (2003) 1.12
Modeling stem cell population growth: incorporating terms for proliferative heterogeneity. Stem Cells (2003) 1.06
Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models. Eur J Immunol (1995) 1.02
A quantitative method for the analysis of mammalian cell proliferation in culture in terms of dividing and non-dividing cells. Cell Prolif (1995) 0.98
Study on myofibroblast differentiation in the stromal cells of Wharton's jelly: expression and localization of alpha-smooth muscle actin. Early Hum Dev (1998) 0.95
Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Exp Hematol (2005) 0.88
Defining the myofibroblast: normal tissues, with special reference to the stromal cells of Wharton's jelly in human umbilical cord. J Submicrosc Cytol Pathol (1994) 0.86
Chasing a cellular fountain of youth. Nat Biotechnol (2005) 0.83
Isolation and culture of smooth muscle cells from human umbilical cord arteries. In Vitro Cell Dev Biol (1985) 0.83
Reagent safety issues surface for cell/tissue therapies. Nat Biotechnol (2004) 0.81
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol (2004) 2.78
Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol (2007) 2.41
Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials (2007) 1.48
Pericyte-based human tissue engineered vascular grafts. Biomaterials (2010) 1.25
Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng Part A (2010) 1.21
The vascular wall as a source of stem cells. Ann N Y Acad Sci (2005) 1.20
Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell (2008) 1.19
The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci (2002) 1.19
Differentiation of intervertebral notochordal cells through live automated cell imaging system in vitro. Spine (Phila Pa 1976) (2009) 1.19
The synergistic effect of treadmill running on stem-cell transplantation to heal injured skeletal muscle. Tissue Eng Part A (2010) 1.08
Placental perivascular cells for human muscle regeneration. Stem Cells Dev (2010) 1.08
GATA4 regulates estrogen receptor-alpha-mediated osteoblast transcription. Mol Endocrinol (2011) 0.98
Generalized bacterial genome editing using mobile group II introns and Cre-lox. Mol Syst Biol (2013) 0.90
From pericytes to perivascular tumours: correlation between pathology, stem cell biology, and tissue engineering. Int Orthop (2014) 0.90
Neuromuscular electrical stimulation as a method to maximize the beneficial effects of muscle stem cells transplanted into dystrophic skeletal muscle. PLoS One (2013) 0.87
The role of the biochemical and biophysical environment in chondrogenic stem cell differentiation assays and cartilage tissue engineering. Cell Biochem Biophys (2008) 0.87
Human muscle-derived cell populations isolated by differential adhesion rates: phenotype and contribution to skeletal muscle regeneration in Mdx/SCID mice. Tissue Eng Part A (2011) 0.84
Human myogenic endothelial cells exhibit chondrogenic and osteogenic potentials at the clonal level. J Orthop Res (2013) 0.84
Pericyte antigens in angiomyolipoma and PEComa family tumors. Med Oncol (2015) 0.83
Cell therapy for muscle regeneration and repair. Phys Med Rehabil Clin N Am (2005) 0.81
Growth kinetics of rat mesenchymal stem cells from 3 potential sources: bone marrow, periosteum and adipose tissue. J Med Assoc Thai (2012) 0.78
Automated live cell imaging systems reveal dynamic cell behavior. Biotechnol Prog (2011) 0.78
[The sex of muscle stem cells: must it be taken into account?]. Med Sci (Paris) (2007) 0.76
Adventitial Cells and Perictyes Support Chondrogenesis Through Different Mechanisms in 3-Dimensional Cultures With or Without Nanoscaffolds. J Biomed Nanotechnol (2015) 0.75